Accor S.A. Inh. sell BiotechBee
Start price
22.09.22
/
60%
€21.98
Target price
31.12.24
€16.00
Performance (%)
8.28%
End price
02.01.23
€23.80
Summary
This prediction ended on 02.01.23 with a price of €23.80. With a performance of 8.28%, the SELL prediction by BiotechBee for Accor S.A. Inh. was trending in the wrong direction BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Accor S.A. Inh. | -0.292% | -0.292% | 0.930% | 78.180% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to BiotechBee what are the pros and cons of Accor S.A. Inh. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Accor S.A. Inh. diskutieren
Sell mit Kursziel 16,0